Yoneda Labs Secures $4M Seed Funding to Revolutionize AI-Powered Drug Discovery with Robotics Lab.
Yoneda Labs leverages AI to enhance drug discovery processes.
Company Name: Yoneda Labs
Location: San Francisco, CA
Sector: AI-powered Drug Discovery
Funding Details: Raised $4M in Seed funding from Khosla Ventures, 500 Emerging Europe, 468 Capital, Fellows Fund, and Y Combinator.
Purpose of Investment: To expand development efforts, including building out a robotics lab to enhance their AI chemical manufacturing model.
Leadership: Co-founded by Michal Mgeladze-Arciuch, Jan Oboril, and Daniel Vlasits.
Product: Yoneda Labs is developing a foundation AI model for chemical manufacturing, specifically targeting chemists in drug discovery. The model aims to improve the efficiency and success rate of chemical reactions critical to developing new pharmaceuticals.
About Company: Yoneda Labs leverages AI to enhance drug discovery processes. Their model predicts successful chemical reactions, offering significant improvements over traditional methods, where a high rate of experiments typically fail.
